Exscientia (EXAI) Stock Chart & Stock Price History $5.01 +0.11 (+2.24%) (As of 11/4/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Exscientia Stock Price Performance5 Day Performance-2.34%1 Month Performance+8.91%3 Month Performance+7.97%6 Month Performance+7.28%Year-To-Date Performance-21.84%1 Year Performance-13.77% Receive EXAI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Weiss RatingsProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. EXAI Stock Chart for Tuesday, November, 5, 2024 EXAI Chart by TradingView Exscientia Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/04/2024$4.90$5.01+2.24%$5.05$4.80512,945 shs$605.64 million11/01/2024$4.86$4.90+0.82%$5.04$4.90218,779 shs$592.36 million10/31/2024$5.13$4.86-5.26%$5.09$4.83446,539 shs$587.51 million10/30/2024$5.11$5.13+0.39%$5.26$5.08340,467 shs$620.15 million10/29/2024$5.23$5.11-2.29%$5.24$5.05283,024 shs$617.73 million10/28/2024$4.92$5.23+6.30%$5.25$4.92730,371 shs$632.24 million Get the Latest News and Ratings for EXAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter. 10/25/2024$4.80$4.92+2.50%$5.01$4.80339,951 shs$594.76 million10/24/2024$4.87$4.80-1.44%$4.89$4.72278,075 shs$580.26 million10/23/2024$5.05$4.87-3.56%$5.03$4.76434,035 shs$588.72 million10/22/2024$5.09$5.05-0.79%$5.15$4.99276,976 shs$610.48 million10/21/2024$5.21$5.09-2.30%$5.22$4.97436,065 shs$615.32 million10/18/2024$5.06$5.21+2.96%$5.22$5.03509,051 shs$629.82 million10/17/2024$5.29$5.06-4.35%$5.41$5.04577,434 shs$611.69 million10/16/2024$5.04$5.29+4.96%$5.35$5.04471,583 shs$639.49 million10/15/2024$5.08$5.04-0.79%$5.11$4.92684,338 shs$609.27 million10/14/2024$4.97$5.08+2.21%$5.13$4.90901,070 shs$614.11 million10/11/2024$4.71$4.97+5.52%$5.00$4.64563,420 shs$600.81 million10/10/2024$4.62$4.71+1.95%$4.71$4.54482,067 shs$569.38 million10/09/2024$4.81$4.62-3.95%$4.93$4.61404,914 shs$558.50 million10/08/2024$4.64$4.81+3.66%$4.82$4.61480,869 shs$581.47 million10/07/2024$4.60$4.64+0.87%$4.64$4.51284,214 shs$560.92 million10/04/2024$4.58$4.60+0.44%$4.72$4.55315,773 shs$556.08 million10/03/2024$4.60$4.58-0.43%$4.70$4.54495,103 shs$553.66 million10/02/2024$4.61$4.60-0.22%$4.76$4.46625,711 shs$556.08 million10/01/2024$4.88$4.61-5.53%$4.88$4.58695,737 shs$557.29 million09/30/2024$5.06$4.88-3.56%$5.14$4.83627,672 shs$589.93 million09/27/2024$5.30$5.06-4.53%$5.41$5.05609,918 shs$611.69 million09/26/2024$5.14$5.30+3.11%$5.31$5.06648,576 shs$640.70 million09/25/2024$5.11$5.14+0.59%$5.30$5.09541,720 shs$621.36 million09/24/2024$5.04$5.11+1.39%$5.20$5.00520,319 shs$617.73 million09/23/2024$5.04$5.04$5.12$5.00571,258 shs$609.27 million09/20/2024$5.20$5.04-3.08%$5.19$5.043.58 million shs$609.27 million09/19/2024$5.22$5.20-0.38%$5.39$5.14932,806 shs$628.61 million09/18/2024$5.03$5.22+3.78%$5.55$5.081.02 million shs$631.03 million09/17/2024$5.06$5.03-0.59%$5.27$5.02806,537 shs$608.06 million09/16/2024$5.03$5.06+0.60%$5.11$4.87488,847 shs$611.69 million09/13/2024$5.08$5.03-0.98%$5.22$5.00231,137 shs$638.91 million09/12/2024$5.01$5.08+1.40%$5.14$4.92280,736 shs$614.11 million09/11/2024$4.79$5.01+4.59%$5.04$4.79431,100 shs$605.64 million09/10/2024$4.85$4.79-1.24%$4.85$4.73736,543 shs$608.43 millionThis company will win the AI race (Ad)Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse. You must read this new presentation from Porter Stansberry.09/09/2024$4.90$4.85-1.02%$4.90$4.66517,916 shs$616.05 million09/06/2024$4.88$4.90+0.41%$4.93$4.68408,726 shs$592.35 million09/05/2024$4.96$4.88-1.61%$5.06$4.85397,003 shs$589.93 million09/04/2024$4.91$4.96+1.02%$5.24$4.81625,775 shs$599.60 million09/03/2024$5.56$4.91-11.69%$5.39$4.751.44 million shs$593.56 million09/02/2024$5.56$5.56$5.93$5.53752,700 shs$672.13 million08/30/2024$5.66$5.56-1.77%$5.93$5.53750,713 shs$672.13 million08/29/2024$5.55$5.66+1.98%$5.90$5.45882,597 shs$684.22 million08/28/2024$5.81$5.55-4.48%$5.75$5.45578,014 shs$670.92 million08/27/2024$6.00$5.81-3.17%$5.93$5.69343,853 shs$702.35 million08/26/2024$6.00$6.00$6.06$5.80903,874 shs$725.32 million08/23/2024$5.68$6.00+5.63%$6.01$5.70701,668 shs$725.32 million08/22/2024$5.83$5.68-2.57%$5.86$5.61727,248 shs$686.64 million08/21/2024$5.53$5.83+5.42%$5.85$5.47734,562 shs$704.77 million08/20/2024$5.49$5.53+0.73%$5.57$5.36579,704 shs$668.51 million08/19/2024$5.32$5.49+3.20%$5.51$5.05741,535 shs$663.67 million08/16/2024$5.30$5.32+0.38%$5.50$5.21534,373 shs$643.12 million08/15/2024$5.45$5.30-2.75%$5.45$5.01643,734 shs$640.70 million08/14/2024$5.00$5.45+9.00%$5.50$4.761.15 million shs$658.83 million08/13/2024$4.86$5.00+2.88%$5.01$4.65710,279 shs$604.44 million08/12/2024$5.05$4.86-3.76%$5.20$4.63713,724 shs$587.51 million08/09/2024$5.27$5.05-4.17%$5.27$5.02681,629 shs$610.48 million08/08/2024$4.50$5.27+17.11%$5.65$5.002.77 million shs$637.07 million08/07/2024$4.83$4.50-6.83%$5.04$4.50383,766 shs$543.99 million08/06/2024$4.26$4.83+13.38%$5.02$4.26579,955 shs$583.88 million08/05/2024$4.64$4.26-8.19%$4.29$3.801.15 million shs$514.98 million Related Companies Relay Therapeutics Stock Chart AbCellera Biologics Stock Chart Schrödinger Stock Chart Longboard Pharmaceuticals Stock Chart Scholar Rock Stock Chart SpringWorks Therapeutics Stock Chart Keros Therapeutics Stock Chart Vericel Stock Chart Akero Therapeutics Stock Chart Mirum Pharmaceuticals Stock Chart Receive EXAI Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Exscientia and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EXAI) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exscientia plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Exscientia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EXAI Stock Alerts